BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
75.26
+0.67 (0.90%)
Apr 13, 2026, 11:41 AM EDT - Market open
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $14.59 billion as of April 13, 2026. Its market cap has increased by 112.50% in one year.
Market Cap
14.59B
Enterprise Value
16.01B
1-Year Change
112.50%
Ranking
Category
Stock Price
$75.26
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $14.59B, an increase of 339.49%. That is a compound annual growth rate of 24.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 14.46B | -1.90% |
| Dec 31, 2025 | 14.74B | 184.24% |
| Dec 31, 2024 | 5.19B | -26.16% |
| Dec 29, 2023 | 7.02B | 516.56% |
| Dec 30, 2022 | 1.14B | -53.61% |
| Dec 31, 2021 | 2.46B | -71.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roivant Sciences | 20.19B |
| Incyte | 19.12B |
| Revolution Medicines | 19.11B |
| Genmab | 17.25B |
| Summit Therapeutics | 15.25B |
| Ascendis Pharma | 14.78B |
| Ionis Pharmaceuticals | 12.42B |
| Jazz Pharmaceuticals | 11.96B |